Thursday 23 April |
RELX |
CRH |
Alumasc Group (re capital reorganisation) |
N4 Pharma |
AFC Energy |
CLS Holdings |
Aggreko |
Croda International |
Blencowe Resources (re reverse takeover) |
Meggitt |
Taylor Wimpey |
Tullow Oil |
Alliance Trust |
Friday 24 April |
St Modwen Properties |
AssetCo |
HSBC Holdings |
Rotork |
Pearson |
ITV |
Senior |
Monday 27 April |
Hostelworld Group |
Simplybiz Group |
Watchstone Group (re cash return) |
Merchants Trust (re issue of share capital) |
Safestyle UK (re placing) |
Polymetal International |
Tuesday 28 April |
Travis Perkins |
Aptitude Software |
Weir |
Hammerson |
Wednesday 29 April |
Nichols |
Synthomer |
Grafton Group |
Royal Bank of Scotland |
Apax Global |
Lancashire Holdings |
Greencoat Renewables |
Proteome |
Spirent Communications |
Witan Investment Trust |
Unilever |
Elementis |
Persimmon |
AstraZeneca |
Shoe Zone (re cancel dividend) |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
IN BRIEF: Proteome Sciences promises AGM return to growth in 2024
Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "confident and well positioned to see the business return to growth in 2024". The company swung to a loss in 2023, as revenue fell by 36% due to a delay in the timing of services contracts. Since the start of 2024, Proteome has seen "significant" customer engagement and interest in proteomics services, including a GBP500,000 contract for an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services, announced late last month.
Read more